We investigated the diagnosis capability and extent of anti-RA 33 positivity and clinical characteristics in patients with rheumatoid arthritis (RA). We highlight a strong negative correlation between anti-RA 33 positivity and the quality of life. Anti-RA 33 antibodies may exert helpful effects determining prognosis in established RA patients though have poor diagnostic capability.